Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves

Introduction. The article presents the results of a study of the physicochemical properties of dry extract of olive leaves, standardized by hydroxythyrozol - a biologically active substance that is part of the chemical composition of aerial parts of the olive tree.Aim. The purpose of the study is to...

Full description

Bibliographic Details
Main Authors: M. S. Maslennikova, N. L. Solovyova
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-08-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/998
_version_ 1797874952584560640
author M. S. Maslennikova
N. L. Solovyova
author_facet M. S. Maslennikova
N. L. Solovyova
author_sort M. S. Maslennikova
collection DOAJ
description Introduction. The article presents the results of a study of the physicochemical properties of dry extract of olive leaves, standardized by hydroxythyrozol - a biologically active substance that is part of the chemical composition of aerial parts of the olive tree.Aim. The purpose of the study is to develop tablet Formulations containing dry extract of olive leaves and to standardize by hydroxythyrozol by reversed-phase-HPLC method on the main substancecontent.Materials and methods. Substance of dry extract of olive leaves, microcrystalline cellulose (Avicel® PH-112), Aerosil® (Aeroperl® 300 Pharma), Ludipress® (Ludipress®), lactose, potato starch, sodium salt of carboxymethyl starch, magnesium stearate, direct pressing, HPLC.Results and discussion. Studies of the physicochemical properties of dry extract of olive leaves have been carried out. Selected excipients for the study of tablettable masses. Formulations for further tabletting have been developed. A complex of studies of the obtained tablets was carried out according to Russian Pharmacopoeia XIV for compliance with quality indicators.Conclusion. The biological properties of dry extract of olive leaves are have been studied, indicating the prospect of developing drugs based on it. Formulations of tablets with dry extract of olive leaves have been developed and their quality indicators have been investigated.
first_indexed 2024-04-10T01:38:58Z
format Article
id doaj.art-42e972620b9144cc9f6134ad59b950ce
institution Directory Open Access Journal
issn 2305-2066
2658-5049
language Russian
last_indexed 2024-04-10T01:38:58Z
publishDate 2021-08-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj.art-42e972620b9144cc9f6134ad59b950ce2023-03-13T09:14:02ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492021-08-01103475310.33380/2305-2066-2021-10-3-47-53847Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive LeavesM. S. Maslennikova0N. L. Solovyova1ФИЦ питания, биотехнологии и безопасности пищиИнститут Фармации им. А.П. Нелюбина, Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет)Introduction. The article presents the results of a study of the physicochemical properties of dry extract of olive leaves, standardized by hydroxythyrozol - a biologically active substance that is part of the chemical composition of aerial parts of the olive tree.Aim. The purpose of the study is to develop tablet Formulations containing dry extract of olive leaves and to standardize by hydroxythyrozol by reversed-phase-HPLC method on the main substancecontent.Materials and methods. Substance of dry extract of olive leaves, microcrystalline cellulose (Avicel® PH-112), Aerosil® (Aeroperl® 300 Pharma), Ludipress® (Ludipress®), lactose, potato starch, sodium salt of carboxymethyl starch, magnesium stearate, direct pressing, HPLC.Results and discussion. Studies of the physicochemical properties of dry extract of olive leaves have been carried out. Selected excipients for the study of tablettable masses. Formulations for further tabletting have been developed. A complex of studies of the obtained tablets was carried out according to Russian Pharmacopoeia XIV for compliance with quality indicators.Conclusion. The biological properties of dry extract of olive leaves are have been studied, indicating the prospect of developing drugs based on it. Formulations of tablets with dry extract of olive leaves have been developed and their quality indicators have been investigated.https://www.pharmjournal.ru/jour/article/view/998гидрокситирозолполифенолысухой экстракт листьев оливывспомогательные веществаоф-вэжх
spellingShingle M. S. Maslennikova
N. L. Solovyova
Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves
Разработка и регистрация лекарственных средств
гидрокситирозол
полифенолы
сухой экстракт листьев оливы
вспомогательные вещества
оф-вэжх
title Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves
title_full Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves
title_fullStr Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves
title_full_unstemmed Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves
title_short Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves
title_sort development of compositions and technologies for producing tablets with hydroxythyrozol standardized extract of olive leaves
topic гидрокситирозол
полифенолы
сухой экстракт листьев оливы
вспомогательные вещества
оф-вэжх
url https://www.pharmjournal.ru/jour/article/view/998
work_keys_str_mv AT msmaslennikova developmentofcompositionsandtechnologiesforproducingtabletswithhydroxythyrozolstandardizedextractofoliveleaves
AT nlsolovyova developmentofcompositionsandtechnologiesforproducingtabletswithhydroxythyrozolstandardizedextractofoliveleaves